| 6.9 -0.23 (-3.23%) | 06-18 10:44 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term | |
|||
| Targets | 6-month : | 9.39 | 1-year : | 10.22 |
| Resists | First : | 8.04 | Second : | 8.75 |
| Pivot price | 7.38 |
|||
| Supports | First : | 6.9 | Second : | 5.74 |
| MAs | MA(5) : | 7.08 |
MA(20) : | 7.44 |
| MA(100) : | 8.6 |
MA(250) : | 10.74 |
|
| MACD | MACD : | -0.3 |
Signal : | -0.2 |
| %K %D | K(14,3) : | 13.9 |
D(3) : | 16.1 |
| RSI | RSI(14): 35.7 |
|||
| 52-week | High : | 17.74 | Low : | 5.93 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ DRIO ] has closed above bottom band by 8.7%. Bollinger Bands are 48.5% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 11 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 7.22 - 7.27 | 7.27 - 7.31 |
| Low: | 6.93 - 6.98 | 6.98 - 7.02 |
| Close: | 7.06 - 7.14 | 7.14 - 7.21 |
DarioHealth Corp. is a digital therapeutics enterprise operating across the United States, Canada, the European Union, Australia, and New Zealand. The company delivers a suite of digital health solutions, including its 'Dario' metabolic programs designed to address conditions like diabetes, hypertension, and weight management. They also offer 'Dario Musculoskeletal' for preventing and treating common MSK conditions, and 'Dario' behavioral health solutions to improve access to evidence-based care. Their offerings extend to general chronic condition management solutions and DarioEngage, a proprietary care management platform. In terms of hardware, DarioHealth provides smart glucose meters, Bluetooth-connected blood pressure cuffs, digital scales, biofeedback sensor devices, and disposables such as test strip cartridges and lancets for blood glucose monitoring systems. Furthermore, they offer comprehensive diabetes management programs that integrate lifestyle changes, healthy eating guidance, advanced tracking tools, and live coaching. Founded in 2011, the company was formerly known as LabStyle Innovations Corp. before officially changing its name to DarioHealth Corp. in July 2016. Its headquarters are located in New York, New York.
Thu, 18 Jun 2026
DarioHealth Corp (DRIO) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Wed, 17 Jun 2026
DarioHealth (DRIO) upgraded to buy: Here's why - MSN
Wed, 17 Jun 2026
DarioHealth Corp (DRIO) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Wed, 17 Jun 2026
DarioHealth Corp (DRIO) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Mon, 08 Jun 2026
Digital diabetes platform linked to fewer stays, 14.3% weight loss - Stock Titan
Wed, 13 May 2026
DarioHealth Reports First Quarter 2026 Financial and Operating Results - PR Newswire
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Diagnostics & Research
|
|
| Shares Out | 7 (M) |
| Shares Float | 5 (M) |
| Held by Insiders | 21 (%) |
| Held by Institutions | 12.1 (%) |
| Shares Short | 71 (K) |
| Shares Short P.Month | 67 (K) |
| EPS | -8.5 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 8.55 |
| Profit Margin | -192.3 % |
| Operating Margin | -130.9 % |
| Return on Assets (ttm) | -19.8 % |
| Return on Equity (ttm) | -59.9 % |
| Qtrly Rev. Growth | -17.3 % |
| Gross Profit (p.s.) | 1.77 |
| Sales Per Share | 2.89 |
| EBITDA (p.s.) | -4.4 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -25 (M) |
| Levered Free Cash Flow | -11 (M) |
| PE Ratio | -0.82 |
| PEG Ratio | 0 |
| Price to Book value | 0.81 |
| Price to Sales | 2.39 |
| Price to Cash Flow | -2.01 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|